Temporal and mutation-specific alterations in Ca2+ homeostasis differentially determine the progression of cTnT-related cardiomyopathies in murine models
Related Experiment Video
Updated: Jun 22, 2026

Isolation, Culture, and Functional Characterization of Adult Mouse Cardiomyoctyes
Published on: September 24, 2013
Pia J Guinto1, Todd E Haim, Candice C Dowell-Martino
1Department of Physiology and Biophysics, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Abstract:
Naturally occurring mutations in cardiac troponin T (cTnT) result in a clinical subset of familial hypertrophic cardiomyopathy. To determine the mechanistic links between thin-filament mutations and cardiovascular phenotypes, we have generated and characterized several transgenic mouse models carrying cTnT mutations. We address two central questions regarding the previously observed changes in myocellular mechanics and Ca(2+) homeostasis: 1) are they characteristic of all severe cTnT mutations, and 2) are they primary (early) or secondary (late) components of the myocellular response? Adult left ventricular myocytes were isolated from 2- and 6-mo-old transgenic mice carrying missense mutations at residue 92, flanking the TNT1 NH(2)-terminal tail domain. Results from R92L and R92W myocytes showed mutation-specific alterations in contraction and relaxation indexes at 2 mo with improvements by 6 mo. Alterations in Ca(2+) kinetics remained consistent with mechanical data in which R92L and R92W exhibited severe diastolic impairments at the early time point that improved with increasing age. A normal regulation of Ca(2+) kinetics in the context of an altered baseline cTnI phosphorylation suggested a pathogenic mechanism at the myofilament level taking precedence for R92L. The quantitation of Ca(2+)-handling proteins in R92W mice revealed a synergistic compensatory mechanism involving an increased Ser16 and Thr17 phosphorylation of phospholamban, contributing to the temporal onset of improved cellular mechanics and Ca(2+) homeostasis. Therefore, independent cTnT mutations in the TNT1 domain result in primary mutation-specific effects and a differential temporal onset of altered myocellular mechanics, Ca(2+) kinetics, and Ca(2+) homeostasis, complex mechanisms which may contribute to the clinical variability in cTnT-related familial hypertrophic cardiomyopathy mutations.
Insights
Specific cardiac troponin T (cTnT) mutations cause familial hypertrophic cardiomyopathy. Mouse models reveal mutation-specific effects on heart cell mechanics and calcium handling, explaining disease variability.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Genetics
Background:
- Mutations in cardiac troponin T (cTnT) are linked to familial hypertrophic cardiomyopathy.
- Understanding the molecular mechanisms underlying cTnT mutations is crucial for explaining disease phenotypes.
Purpose of the Study:
- To investigate the mechanistic links between cTnT mutations and cardiovascular phenotypes.
- To determine if observed changes in myocellular mechanics and calcium homeostasis are common to all severe cTnT mutations and whether they are primary or secondary effects.
Main Methods:
- Generation and characterization of transgenic mouse models with specific cTnT missense mutations (R92L, R92W).
- Isolation and analysis of adult left ventricular myocytes from mice at 2 and 6 months of age.
- Assessment of myocellular mechanics, calcium (Ca2+) kinetics, and Ca2+-handling protein expression.
Main Results:
- R92L and R92W mutations induced mutation-specific alterations in contraction and relaxation, with improvements observed by 6 months.
- Altered Ca2+ kinetics, particularly severe diastolic impairments in R92L and R92W at 2 months, improved with age.
- R92L showed a primary myofilament-level pathogenic mechanism, while R92W exhibited compensatory phospholamban phosphorylation.
Conclusions:
- Independent cTnT mutations in the TNT1 domain cause distinct primary effects.
- Altered myocellular mechanics, Ca2+ kinetics, and homeostasis manifest with differential temporal onset.
- These complex, age-dependent mechanisms contribute to the clinical variability observed in cTnT-related familial hypertrophic cardiomyopathy.

